Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Margaret Hamburg published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 41
» View wsbt.com items only
    Apr 29, 2013 |Story| WSBT-TV
  1. FDA will investigate added caffeine in foods

    WASHINGTON (AP) — Trail mix. Potato chips. And now gum. With a growing number of foods boasting added caffeine for an energy boost, the Food and Drug Administration says it's time to investigate their safety. The FDA's new look at added caffeine...

    Tags: Washington, DC, American Academy of Pediatrics, Energy Drinks, Children's Health, Mars, Inc.

  2. Jan 5, 2013 |Story| WSBT-TV
  3. FDA: New rules will make food safer

    WASHINGTON (AP) — The Food and Drug Administration says its new guidelines would make the food Americans eat safer and help prevent the kinds of foodborne disease outbreaks that sicken or kill thousands of consumers each year. The rules, the...

    Tags: Listeria Outbreak (2011), Washington, DC, Consumers, U.S. Congress, Peanuts

  4. May 13, 2013 |Story| Reuters
  5. U.S. House panel questions resignation of top FDA official

    Reuters
    By Toni Clarke May 13 (Reuters) - A U.S. House of Representatives panel is investigating the circumstances surrounding the resignation from the Food and Drug Administration of its acting deputy commissioner for medical products and tobacco. In a...

    Tags: Republican Party, Johnson & Johnson Inc., U.S. Department of Health and Human Services, Science and Technology, Science

  6. May 8, 2013 |Story| Reuters
  7. REUTERS SUMMIT-Faster drug approvals a tonic for pharma industry

    Reuters
    (For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Ben Hirschler NEW YORK, May 8 (Reuters) - A pickup in new drug approvals, the promise of faster regulatory decisions and more targeted medicines have...

    Tags: Lipitor (drug), New Products, Johnson & Johnson Inc., Schering Plough Corporation, Breast Cancer

  8. May 8, 2013 |Story| Reuters
  9. REUTERS SUMMIT-Drugmakers split as demands for open data mount

    Reuters
    (For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Growing demands for transparency of clinical trial data * Wider disclosure by EU regulator angers drugmakers * GlaxoSmithKline sets up online system for data...

    Tags: Trials, S, Avandia (drug), Science and Technology, Lobbying

  10. May 7, 2013 |Story| Reuters
  11. REUTERS SUMMIT-US budget cuts hit healthcare from flu watch to hospitals

    Reuters
    (For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * CDC chief worries as potential flu pandemic looms * FDA sees long-term consequences in recruitment, future leadership * Tenet takes a $50 million hit,...

    Tags: Science and Technology, U.S. Congress, Medicare, Meningitis, Budgets and Budgeting

  12. May 7, 2013 |Story| Reuters
  13. Judge criticizes FDA move on Plan B, agency warns of precedent

    Reuters
    By Jessica Dye and Toni Clarke NEW YORK, May 7 (Reuters) - A federal judge criticized the U.S. Food and Drug Administration over its refusal to make emergency contraception available to girls of all ages without a prescription, saying the agency's move...

    Tags: Birth Control, Consumers, Trials, Interior Policy, Brooklyn (New York City)

  14. May 1, 2013 |Story| Reuters
  15. FDA approves Plan B for girls as young as 15

    WASHINGTON (Reuters) - The <a id="tinymce" class="mceContentBody " dir="ltr">Food and Drug Administration</a> on Tuesday said it would allow the Plan B One-Step contraceptive to be sold without a prescription to girls as young as 15 years of age.
    Reuters
    WASHINGTON (Reuters) - The Food and Drug Administration on Tuesday said it would allow the Plan B One-Step contraceptive to be sold without a prescription to girls as young as 15 years of age. The announcement partially reverses a December 2011...

    Tags: Birth Control, Women's Health, Kathleen Sebelius, Plan B (drug), U.S. Department of Justice

  16. Apr 30, 2013 |Story| Los Angeles Times
  17. Plan B can be sold to 15-year-olds without prescription, FDA says

    The U.S. Food and Drug Administration announced Tuesday that it has approved the sale of the emergency contraceptive pill, Plan B One-Step, without a prescription for females ages 15 and older.
    The U.S. Food and Drug Administration announced Tuesday that it has approved the sale of the emergency contraceptive pill, Plan B One-Step, without a prescription for females ages 15 and older. The action comes roughly three weeks after a federal...

    Tags: Birth Control, Family Planning, Plan B (drug), Justice System, Judges

  18. Apr 24, 2013 |Story| Los Angeles Times
  19. FDA's counterfeit detection device takes global aim at malaria

    A device that reveals counterfeit drugs in the hands of Food & Drug Administration agents is set to become the newest weapon in the worldwide effort to eradicate malaria, and may soon be used to detect useless look-alikes of drugs that combat cancer,...

    Tags: Corning Incorporated, Science and Technology, Pharmaceuticals, Chemical Industry, Diseases and Illnesses

  20. Apr 16, 2013 |Story| Los Angeles Times
  21. FDA chief vows to get 'aggressive' with compounding pharmacies

    The head of the U.S. Food and Drug Agency endured heavy criticism Tuesday as House members accused the agency of failing to act on complaints against the New England Compounding Center, the Massachusetts firm linked to an outbreak of deadly meningitis.
    The head of the U.S. Food and Drug Agency endured heavy criticism Tuesday as House members accused the agency of failing to act on complaints against the New England Compounding Center, the Massachusetts firm linked to an outbreak of deadly meningitis....

    Tags: Food and Drug Administration, Meningitis

  22. Mar 17, 2013 |Story| Los Angeles Times
  23. Battle over 'biosimilars'

    One of the most promising frontiers in healthcare is biologic medicines &mdash; complex substances derived from living cells that can help fight chronic diseases and cancers. To encourage investment in biologics, Congress in 2010 gave drug companies what amounts to a 12-year monopoly on the substances they developed. Now, supporters of biologics are pushing lawmakers in Sacramento and other state capitals to put new hurdles in the way of knock-off compounds, called "biosimilars."
    One of the most promising frontiers in healthcare is biologic medicines — complex substances derived from living cells that can help fight chronic diseases and cancers. To encourage investment in biologics, Congress in 2010 gave drug companies...

    Tags: General Practitioners, Biotechnology, Science and Technology, U.S. Congress, Pharmaceuticals

 1  2 3 4Next >
Original site for Margaret Hamburg topic gallery.